Navigation Links
Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
Date:2/5/2008

BOTHELL, Wash., Feb. 5 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. ("Nastech") (Nasdaq: NSTK) announced today that it has named members to the MDRNA, Inc. ("MDRNA") Directors Strategic Advisory Board that will provide scientific, financial and corporate governance expertise as Nastech moves to establish MDRNA, currently a wholly-owned subsidiary, as an independent company.

Advisory Board appointees include:

Susan B. Bayh, J.D. has been a director of Nastech since July 2005 as a member of the Compensation and chairman of the Nominating and Corporate Governance Committees of the Board of Directors. Mrs. Bayh currently serves on the boards of directors of Curis, Inc., a therapeutic drug development company, Dendreon Corporation, a therapeutic drug development company, Dyax Corp., a biopharmaceutical company, Emmis Communications, a diversified media company, and Wellpoint, Inc., a Blue Cross / Blue Shield company. In addition, Mrs. Bayh is a member of the Audit and Compensation Committees of the board of directors of Curis, Inc., and a member of the Compensation Committee of the board of directors of Emmis Communications. Previously, Mrs. Bayh also served on the boards of directors of Cubist Pharmaceuticals, Inc., a pharmaceutical company, from 2000 to 2004, and Esperion Therapeutics, Inc., a biopharmaceutical company, from 2000 to 2003. From 1994 to 2004, she was a Distinguished Visiting Professor at the College of Business Administration at Butler University in Indianapolis, Indiana. From 1994 to 2000, she was a Commissioner for the International Joint Commission of the Water Treaty Act between the United States and Canada. From 1989 to 1994, Mrs. Bayh served as an attorney in the Pharmaceutical Division of
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
2. Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
3. Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
4. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
5. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
6. Skinvisible Appoints New Board Member
7. Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors
8. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
9. Crdentia Appoints Charlie Mayhone to Director of Operations for its National Travel Division and Charlotte, North Carolina Market
10. National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council
11. CPF Appoints Mishka Michon Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... In recognition of Veteran’s Day, Discount Labels ... a local organization that provides services to veterans and ... on a couple hundred acres in the hills of ... class fishing, hunting, hiking, horseback riding, 4-wheeling, skeet shooting, ... ago to support U.S. Service men and women, police ...
(Date:12/22/2014)... 2014 7,178 small business owners and ... Friday shopping and opted instead to join Digital Marketer, ... for their 5th annual “Black Friday Boot Camp”. ... to attend the 5 hour online training event and ... to support two Central Texas based charities dedicated to ...
(Date:12/22/2014)... December 22, 2014 NAPW ... Professional Woman of the Year. Ms. Foley is recognized ... the largest, most-recognized networking organization of professional women in ... National Association of Professional Women is a powerfully vibrant ... Local Chapters. , “As a nurse, I felt like ...
(Date:12/22/2014)... Washington, DC (PRWEB) December 22, 2014 ... Nursing Leadership Conference, next month in San ... strategies to address dynamics that often stand in ... authority, and competition. , This premier faculty ... Center for Transformational Leadership, whose mission is to ...
(Date:12/21/2014)... an outstanding online supplier of wedding dresses and women’s ... of Cocktail Dresses for the winter 2014. All these ... trends. , “We take pride in releasing ... of them are offered at greatly discounted rates, up ... to offer a nice shopping experience for global customers.” ...
Breaking Medicine News(10 mins):Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2
... , MONDAY, Feb. 27 (HealthDay News) -- Rapid diagnostic ... flu season could lead to earlier treatment for patients and ... suggest. The 2012 flu season is just beginning and, ... 5 million people worldwide, experts say. Most patients will recover, ...
... news digest: , Summary of a study being ... Clinical Oncology , showing that women who underwent a once-common ... slightly lower on cognitive tests that measure word learning, memory ... cancer. While CMF is no longer the standard ...
... MONDAY, Feb. 27 (HealthDay News) -- If a luxurious-looking car ... That,s the message of a new observational study that contends ... cut off pedestrians and ignore stop-sign etiquette. The new ... experiments done by the researchers found that study participants ...
... By Jenifer Goodwin HealthDay Reporter , SUNDAY, Feb. ... cells from adult human ovaries that can mature into eggs ... which upend longstanding scientific theory, could potentially lead to ... woman,s fertility. It was long believed that women were ...
... -- A second company has issued a voluntary recall of ... lead to incorrect dosing and expose women to unintended pregnancies. ... control pill packets, sold as Norgestimate and Ethinyl Estradiol, do ... these oral contraceptives should immediately switch to another form of ...
... TAK-875, a new treatment for type 2 diabetes, improves blood ... a significantly lower risk of creating a dangerous drop in ... The results of the phase 2 randomized trial were published ... 2 diabetes is the most common form of diabetes accounting ...
Cached Medicine News:Health News:Rapid Flu Tests a Good First Step: Study 2Health News:First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen 2Health News:First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen 3Health News:First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen 4Health News:Are the Rich Really Different From You and Me? 2Health News:Are the Rich Really Different From You and Me? 3Health News:Stem Cell Finding Could Expand Women's Lifetime Supply of Eggs 2Health News:Stem Cell Finding Could Expand Women's Lifetime Supply of Eggs 3Health News:Another Batch of Birth Control Pills Recalled for Faulty Packaging 2Health News:Another Batch of Birth Control Pills Recalled for Faulty Packaging 3Health News:Diabetes drug gets patients with Type 2 diabetes on target 2
(Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals ... 2a study of lonafarnib in patients with chronic ... conducted at the National Institutes of Health (NIH) ... .  The double-blinded, randomized, placebo-controlled, dose ascending study ... daily and 200 mg twice daily for 28 ...
(Date:12/22/2014)... , Dec. 22, 2014  Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced ... been dosed in a pharmacokinetic and pharmacodynamic study ... for neuropathic pain. Racemic methadone is ... various pain states and substitution therapy in opioid ...
(Date:12/19/2014)... N.J. , Dec. 19, 2014  In the Friday, December ... a 16-page supplement dedicated to Healthcare Information Technology (HIT) features Konica ... in Healthcare IT in partnership with several leading healthcare organizations. ... distributed across several major metropolitan markets, such as New ... DC / Baltimore , Minneapolis ...
Breaking Medicine Technology:Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2
... At the 60th Annual Scientific Session and Expo of ... New Orleans, Siemens (NYSE: SI) will demonstrate its ... in the United States are bracing for changes that will ... and the overall value of care. With a comprehensive portfolio ...
... DIEGO, April 4, 2011 OncoSec Medical Incorporated (OTCBB: ONCS), ... cancers with unmet medical needs, announced today that on March ... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ) and ... terms of an asset purchase agreement with Inovio entered into ...
Cached Medicine Technology:Siemens Demonstrates Strategy for Sustainable Cardiovascular Care 2Siemens Demonstrates Strategy for Sustainable Cardiovascular Care 3OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals 2OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals 3OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals 4
... The FR-120F, Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope ... and patient comfort. The latest in ... an increased light guide, and a wide ... very impressive 3.3mm distal tip diameter. ...
... Tip Laryngoscopes are the most ... The articulating tip aids during ... improved view of epiglottis. Available ... styles. We guarantee your complete ...
German Style MacIntosh Fiber Optic Blade Laryngoscopes...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: